Annual Total Debt
$92.43 M
+$6.45 M+7.50%
December 31, 2023
Summary
- As of February 26, 2025, TCRX annual total debt is $92.43 million, with the most recent change of +$6.45 million (+7.50%) on December 31, 2023.
- During the last 3 years, TCRX annual total debt has risen by +$85.00 million (+1143.38%).
- TCRX annual total debt is now at all-time high.
Performance
TCRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$90.36 M
-$717.00 K-0.79%
September 30, 2024
Summary
- As of February 26, 2025, TCRX quarterly total debt is $90.36 million, with the most recent change of -$717.00 thousand (-0.79%) on September 30, 2024.
- Over the past year, TCRX quarterly total debt has increased by +$3.37 million (+3.88%).
- TCRX quarterly total debt is now -2.25% below its all-time high of $92.43 million, reached on December 31, 2023.
Performance
TCRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TCRX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.5% | +3.9% |
| 3 y3 years | +1143.4% | +3.9% |
| 5 y5 years | +1791.4% | +3.9% |
TCRX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1429.6% | -2.3% | +1623.7% |
| 5 y | 5-year | at high | +1791.4% | -2.3% | -100.0% |
| alltime | all time | at high | +1791.4% | -2.3% | -100.0% |
TScan Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $90.36 M(-0.8%) |
| Jun 2024 | - | $91.07 M(-0.8%) |
| Mar 2024 | - | $91.76 M(-0.7%) |
| Dec 2023 | $92.43 M(+7.5%) | $92.43 M(+6.3%) |
| Sep 2023 | - | $86.98 M(-0.9%) |
| Jun 2023 | - | $87.74 M(+2.8%) |
| Mar 2023 | - | $85.31 M(-0.8%) |
| Dec 2022 | $85.98 M | $85.98 M(+153.6%) |
| Sep 2022 | - | $33.90 M(+546.7%) |
| Jun 2022 | - | $5.24 M(-7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.65 M(-6.6%) |
| Dec 2021 | $6.04 M(-18.7%) | $6.04 M(-5.7%) |
| Sep 2021 | - | $6.41 M(-5.5%) |
| Jun 2021 | - | $6.79 M(-5.1%) |
| Mar 2021 | - | $7.15 M(-3.8%) |
| Dec 2020 | $7.43 M(+52.1%) | - |
| Dec 2020 | - | $7.43 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $4.89 M | - |
FAQ
- What is TScan Therapeutics annual total debt?
- What is the all time high annual total debt for TScan Therapeutics?
- What is TScan Therapeutics annual total debt year-on-year change?
- What is TScan Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for TScan Therapeutics?
- What is TScan Therapeutics quarterly total debt year-on-year change?
What is TScan Therapeutics annual total debt?
The current annual total debt of TCRX is $92.43 M
What is the all time high annual total debt for TScan Therapeutics?
TScan Therapeutics all-time high annual total debt is $92.43 M
What is TScan Therapeutics annual total debt year-on-year change?
Over the past year, TCRX annual total debt has changed by +$6.45 M (+7.50%)
What is TScan Therapeutics quarterly total debt?
The current quarterly total debt of TCRX is $90.36 M
What is the all time high quarterly total debt for TScan Therapeutics?
TScan Therapeutics all-time high quarterly total debt is $92.43 M
What is TScan Therapeutics quarterly total debt year-on-year change?
Over the past year, TCRX quarterly total debt has changed by +$3.37 M (+3.88%)